Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

IMVT – Immunovant Inc

Immunovant, Inc.
IMVT
$31.61
Name : Immunovant, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $6,489,815,040.00
EPSttm : -2.84
finviz dynamic chart for IMVT
Immunovant, Inc.
$31.61
2.63%
$0.81
IMVT — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

25.15

Margin Of Safety %

Put/Call OI Ratio

0.27

EPS Next Q Diff

0.14

EPS Last/This Y

0.33

EPS This/Next Y

0.01

Price

31.61

Target Price

45.76

Analyst Recom

1.59

Performance Q

22.9

Upside

-213.9%

Beta

0.81

Ticker: IMVT




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-05-11IMVT29.080.170.2539741
2026-05-12IMVT28.650.170.0039753
2026-05-13IMVT29.240.170.1340346
2026-05-14IMVT28.990.170.5439904
2026-05-15IMVT27.50.170.0739404
2026-05-18IMVT26.530.050.0522489
2026-05-19IMVT26.30.050.0622933
2026-05-20IMVT35.550.050.5523286
2026-05-21IMVT34.160.270.3127935
2026-05-22IMVT34.130.320.2627397
2026-05-26IMVT33.810.310.7927807
2026-05-27IMVT33.410.320.9627859
2026-05-28IMVT33.510.310.0727950
2026-05-29IMVT33.30.310.1228577
2026-06-02IMVT30.910.290.5928911
2026-06-03IMVT31.030.2816.0030338
2026-06-04IMVT32.670.270.0330543
2026-06-05IMVT31.080.271.6930693
2026-06-08IMVT30.780.270.6230766
2026-06-09IMVT31.590.270.1730776
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-05-11IMVT29.073.4-36.9-2.53
2026-05-12IMVT28.613.4-27.6-2.53
2026-05-13IMVT29.241.9-40.5-2.53
2026-05-14IMVT28.981.9-35.1-2.53
2026-05-15IMVT27.491.9-4.6-2.53
2026-05-18IMVT26.551.914.7-2.53
2026-05-19IMVT26.291.90.9-2.53
2026-05-20IMVT35.511.9-168.9-2.53
2026-05-21IMVT34.151.9-147.2-2.53
2026-05-22IMVT34.13- - -2.58
2026-05-26IMVT33.8432.5- -2.39
2026-05-27IMVT33.4032.5- -2.39
2026-05-28IMVT33.4932.5- -2.39
2026-05-29IMVT33.3232.5- -2.39
2026-06-01IMVT32.8632.5- -2.39
2026-06-02IMVT30.8832.5- -2.39
2026-06-03IMVT31.1332.5- -2.44
2026-06-04IMVT32.6732.5- -2.44
2026-06-05IMVT31.0932.5- -2.44
2026-06-08IMVT30.7932.5- -2.44
2026-06-09IMVT31.6132.5- -2.44
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-05-11IMVT15.906.3823.48
2026-05-12IMVT15.906.3822.38
2026-05-13IMVT15.906.3822.38
2026-05-14IMVT15.906.3822.38
2026-05-15IMVT15.906.3822.38
2026-05-18IMVT15.906.3922.38
2026-05-19IMVT15.906.3922.38
2026-05-20IMVT15.906.3922.38
2026-05-21IMVT15.896.3922.38
2026-05-22IMVT15.756.3923.17
2026-05-26IMVT15.331.0022.97
2026-05-27IMVT15.331.0022.97
2026-05-28IMVT15.331.0025.16
2026-05-29IMVT15.331.0025.16
2026-06-02IMVT15.090.6825.16
2026-06-03IMVT15.090.6825.16
2026-06-04IMVT15.130.6825.16
2026-06-05IMVT15.130.6825.16
2026-06-08IMVT15.130.6825.15
2026-06-09IMVT15.140.6825.15
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

-0.67

Avg. EPS Est. Current Quarter

-0.48

Avg. EPS Est. Next Quarter

-0.53

Insider Transactions

15.14

Institutional Transactions

0.68

Beta

0.81

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

7

Growth Score

19

Sentiment Score

24

Actual DrawDown %

30.7

Max Drawdown 5-Year %

-70.4

Target Price

45.76

P/E

Forward P/E

PEG

P/S

P/B

7.56

P/Free Cash Flow

EPS

-2.77

Average EPS Est. Cur. Y​

-2.44

EPS Next Y. (Est.)

-2.44

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.94

Return on Equity vs Sector %

-86.8

Return on Equity vs Industry %

-70.6

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.14

EBIT Estimation

IMVT Healthcare
$31.61
📉
Swing / Pullback
Buy the dip on strong trends
48 /100
WEAK
Trend
10/20
Pullback
11/25
Volume
7/15
Valuation
9/20
TP/AR
3/10
Options
8/10
RSI
53.7
Range 1M
51.4%
Sup Dist
4%
🚀
Momentum Growth
Ride accelerating trends
N/A
33 /100
WEAK
Momentum
8/25
Growth
7/30
Estimates
2/20
Inst/Vol
8/15
Options
8/10
EPS Yr
5.5%
EPS NY
3.1%
52W%
76.7%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +44.8% upside
Quality
2/30
Valuation
10/30
Growth
4/25
Stability
7/10
LT Trend
1/5
Upside
+44.8%
Quality
7
Immunovant, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 315
Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.
IMVT

Latest News

Caricamento notizie per IMVT
stock quote shares IMVT – Immunovant Inc Stock Price stock today
news today IMVT – Immunovant Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch IMVT – Immunovant Inc yahoo finance google finance
stock history IMVT – Immunovant Inc invest stock market
stock prices IMVT premarket after hours
ticker IMVT fair value insiders trading